Results 251 to 260 of about 389,869 (294)

CytoSorb hemoadsorption of apixaban during cardio-pulmonary bypass for heart transplantation. [PDF]

JHLT Open
Frering A, Abi Lutfallah A, Carillion A, Wendt D, Leprince P, Bougle A, Lebreton G.   +6 more
europepmc   +1 more source

Implementing Pre‐Emptive Pharmacogenetics: Impact of Early Pharmacogenetic Screening in a Pediatric Oncology Cohort of 1,151 Subjects

Clinical Pharmacology &Therapeutics, EarlyView.
In pediatric oncology, pharmacogenetic guidelines are underutilized and the potential impact of pre‐emptive pharmacogenetic screening remains largely unexplored despite this field's need for individualized approaches. While comprehensive pharmacogenetic guidelines are not yet available for all anticancer drugs, evidence‐based recommendations exist for ...
Emma C. Bernsen, Eugène T.P. Verwiel, Maaike van der Lee, Jesse J. Swen, Marcel Santoso, Leiah J. Brigitha, Rick Admiraal, Bastiaan B.J. Tops, Alwin D.R. Huitema, Patrick Kemmeren, Jayne Y. Hehir‐Kwa, Lidwien M. Hanff, Meta H.M. Diekstra   +12 more
wiley   +1 more source

Heart transplantation performance in China: Five-year experience after transplantation system reform. [PDF]

Chin Med J (Engl)
Lin S, Chen S, Zheng S, Liu S, Huang J, Shi Y, Wang H, Zheng Z, China Heart Transplant Registry Collaborative Group.   +8 more
europepmc   +1 more source

Exploring the Association Between Intra‐Patient Variability in Trough Concentration of Pazopanib and Clinical Outcomes in Renal Cell Carcinoma and Soft Tissue Sarcoma Patients

Clinical Pharmacology &Therapeutics, EarlyView.
Pazopanib is an oral tyrosine kinase inhibitor used in patients with either metastatic renal cell carcinoma or soft tissue sarcoma. Pazopanib has a high interindividual variability in pharmacokinetics and pharmacodynamics and a well‐established exposure–response relationship. Therefore, therapeutic drug monitoring is recommended to improve the efficacy–
Amy Rieborn, Eline L. Giraud, Teun van Gelder, Hans Gelderblom, Nielka P. van Erp, Tom van der Hulle, Dirk Jan A. R. Moes   +6 more
wiley   +1 more source

Correlation Between the Distance From Donors and Ischemic Time in Heart Transplantation of Korea and Its Clinical Impact. [PDF]

J Korean Med Sci
Jin JY, Lee CH, Lim MH, Lee SY, Ju MH, Je HG.   +5 more
europepmc   +1 more source

Association of liver biopsy pathology on outcome of patients undergoing heart transplantation. [PDF]

JHLT Open
Eichenwald LS, Karagozian R, Eichenwald AJ, Morrissey J, Kini S, Stein A, Vest AR.   +6 more
europepmc   +1 more source

Clinical Outcomes of Machine Perfusion and Temperature Control Systems in Heart Transplantation: Where We Stand. [PDF]

J Clin Med
Nasim U, Dorken-Gallastegi A, Dadson P, Hong Y.   +3 more
europepmc   +1 more source

Donor Heart Preservation for Heart Transplantation: Single-Center Experience with Three Different Techniques. [PDF]

J Clin Med
Lechiancole A, Gliozzi G, Sponga S, Visentin P, Beltrami A, Piani D, Benedetti G, Daffarra C, Dralov A, Meneguzzi M, Guzzi G, Di Lorenzo A, Stella L, Bortolotti U, Livi U, Vendramin I.   +15 more
europepmc   +1 more source

Case Report: Heart Transplantation for Refractory <i>Candida tropicalis</i> Endocarditis: A Case Report and Literature Review. [PDF]

Microorganisms
El Nouwar R, Larranaga Lapique E, Vanden Eynden F, Martiny D, Remmelink M, Roussoulières A, Hites M.   +6 more
europepmc   +1 more source